19 August 2024 Scandion Oncology strengthens partnering outreach Download Presentation Webcast Workbook
16 August 2024 Scandion Oncology achieves Maximum Tolerated Dose for CORIST part 3 Download Presentation Webcast Workbook
11 July 2024 SCANDION ONCOLOGY’S RIGHTS ISSUE REGISTERED WITH THE DANISH BUSINESS AUTHORITY Download Presentation Webcast Workbook
1 July 2024 Scandion Oncology board member Michel Ducreux steps down, joins advisory board Download Presentation Webcast Workbook
25 June 2024 SCANDION ONCOLOGY ANNOUNCES OUTCOME OF THE RIGHTS ISSUE Download Presentation Webcast Workbook
3 June 2024 Scandion announces change of Certified Adviser to Vator Securities Download Presentation Webcast Workbook
23 May 2024 SCANDION ONCOLOGY ANNOUNCES THE FINAL TERMS OF THE RIGHTS ISSUE Download Presentation Webcast Workbook
16 May 2024 Invitation to Scandion Oncology webcast and conference call May 22, 2024 Download Presentation Webcast Workbook
13 May 2024 Scandion confirms positive final Phase Ib data from PANTAX trial with SCO-101 Download Presentation Webcast Workbook
6 May 2024 Scandion Oncology Announces Results of Annual General Meeting and Constitution of the Board of Directors Download Presentation Webcast Workbook
19 April 2024 Scandion Oncology – Notice convening the Annual General Meeting Download Presentation Webcast Workbook